| Literature DB >> 31652567 |
Amira A Moawad1,2, Helmut Hotzel3, Omnia Awad4, Uwe Roesler5, Hafez M Hafez6, Herbert Tomaso7, Heinrich Neubauer8, Hosny El-Adawy9,10.
Abstract
Coagulase-negative staphylococci (CoNS) are gaining much attention as causative agents of serious nosocomial infections in humans. This study aimed to determine the prevalence and phenotypic antimicrobial resistance of CoNS as well as the presence of resistance-associated genes in CoNS isolated from turkey farms in Egypt. Two hundred and fifty cloacal swabs were collected from apparently healthy turkeys in Egypt. Suspected isolates were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The susceptibility testing of CoNS isolates against 20 antimicrobial agents was performed using the broth microdilution test. The presence of resistance-associated genes like mecA, vanA, blaZ, erm(A), erm(B), erm(C), aac-aphD, optrA, valS, and cfr was determined. Thirty-nine CoNS were identified. All isolates were phenotypically resistant to trimethoprim/sulfamethoxazole, penicillin, ampicillin, and tetracycline. The resistance rates to erythromycin, chloramphenicol, oxacillin, daptomycin, and tigecycline were 97.4%, 94.9%, 92.3%, 89.7%, and 87.2%, respectively. Thirty-one isolates were resistant to linezolid (79.5%). Low resistance rate was detected for both imipenem and vancomycin (12.8%). The erm(C) gene was identified in all erythromycin phenotypically resistant isolates, whereas two resistant isolates possessed three resistance-conferring genes erm(A), erm(B), and erm(C). The cfr and optrA genes were detected in 11 (35.5%) and 12 (38.7%) of the 31 linezolid-resistant isolates. The mecA, aac-aphD, and blaZ genes were identified in 22.2%, 41.9%, and 2.6% of phenotypically resistant isolates to oxacillin, gentamicin, and penicillin, respectively. This is the first study revealing the correlation between linezolid resistance and presence of cfr and optrA genes in CoNS isolates from Egypt, and it can help to improve knowledge about the linezolid resistance mechanism.Entities:
Keywords: CoNS; Egypt; Turkey; linezolid; staphylococci
Year: 2019 PMID: 31652567 PMCID: PMC6843140 DOI: 10.3390/microorganisms7100476
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Investigated turkey farms in northern Egypt, the number of birds, and the number of collected samples.
| Number of | Governorates | Total | ||||
|---|---|---|---|---|---|---|
| Dakahliya | Damietta | Kafr El-Sheikh | Sharkiya | Gharbiya | 5 | |
| Farms * | 4 | 3 | 2 | 2 | 1 | 12 |
| Birds | 5000 | 2100 | 1200 | 1800 | 800 | 10,900 |
| Samples | 71 | 44 | 46 | 46 | 43 | 250 |
* Each farm reared one flock.
Antibiotic susceptibility of 39 coagulase-negative Staphylococcus isolates from turkey flocks determined by broth microdilution test.
| Antibiotic | Class | 0.03125 | 0.0625 | 0.125 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | R (%) | MIC50 | MIC90 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amikacin (AMK) # | Aminoglycoside | 3 | 2 | 5 | 6 | 23 | 29 (74.4) | 64 | 64 | |||||||||
| Ampicillin (AMP) * | β-Lactam (Penicillin) | 22 | 3 | 14 | 39 (100) | 2 | 16 | |||||||||||
| Cefoxitin (COX) * | β-Lactam (Cephalosporin) | 10 | 3 | 1 | 25 | 29 (74.4) | 16 | 16 | ||||||||||
| Chloramphenicol (CMP) * | Miscellaneous | 2 | 2 | 35 | 37(94.9) | 64 | 64 | |||||||||||
| Ciprofloxacin (CIP) # | Fluoroquinolone | 2 | 5 | 6 | 26 | 32(82) | 4 | 4 | ||||||||||
| Daptomycin (DPT) * | Cyclic lipopeptide | 3 | 1 | 35 | 35 (89.7) | 4 | 4 | |||||||||||
| Erythromycin (ERY) # | Macrolide | 1 | 2 | 36 | 38 (97.4) | 8 | 8 | |||||||||||
| Gentamicin (GEN) # | Aminoglycoside | 6 | 2 | 5 | 3 | 23 | 31 (79.5) | 8 | 8 | |||||||||
| Imipenem (IMP) * | β-Lactam (Carbapenem) | 8 | 8 | 7 | 4 | 3 | 4 | 2 | 3 | 5 (12.8) | 0.5 | 8 | ||||||
| Levofloxacin (LEV) # | Fluoroquinolone | 5 | 2 | 2 | 30 | 32 (82) | 4 | 4 | ||||||||||
| Linezolid (LIZ) # | Oxazolidinone | 5 | 3 | 4 | 27 | 31 (79.5) | 16 | 16 | ||||||||||
| Moxifloxacin (MOX) * | Fluoroquinolone | 2 | 3 | 2 | 32 | 32 (82) | 2 | 2 | ||||||||||
| Oxacillin (OXA) * | β-Lactam(Penicillin) | 3 | 6 | 3 | 3 | 4 | 20 | 36 (92.3) | 16 | 16 | ||||||||
| Penicillin (PEN) * | β-Lactam (Penicillin) | 3 | 3 | 33 | 39 (100) | 8 | 8 | |||||||||||
| Rifampicin (RAM) * | Ansamycin | 11 | 28 | 28 (71.8) | 4 | 4 | ||||||||||||
| Teicoplanin (TPL) # | Glycopeptide | 6 | 20 | 6 | 7 | 13 (33.3) | 2 | 16 | ||||||||||
| Tetracycline (TET) # | Tetracycline | 4 | 35 | 39 (100) | 16 | 16 | ||||||||||||
| Tigecyclin (TGC) * | Glycylcycline | 3 | 1 | 1 | 34 | 34 (87.2) | 1 | 1 | ||||||||||
| Trimethoprim/Sulfamethoxazole (T/S) * | Diaminopyrimidine/Sulfonamide | 39a* | 39 (100) | 4/76 | 4/76 | |||||||||||||
| Vancomycin (VAN) # | Glycopeptide | 10 | 9 | 8 | 7 | 4 | 1 | 5 (12.8) | 2 | 8 |
A thick black line indicates the break point between clinically sensitive and resistant strains; R—resistance rate. # EUCAST; * CLSI.
Primers and their sequences used in this study.
| Gene | Antimicrobial Agent | Primer | Primer Sequence (5′–3′) | Reference |
|---|---|---|---|---|
| Methicillin/Oxacillin | TCC AGA TTA CAA CTT CAC CAG G | [ | ||
| CCA CTT CAT ATC TTG TAA CG | ||||
| Erythromycin | TAT CTT ATC GTT GAG AAG GGA TT | |||
| CTA CAC TTG GCT TAG GAT GAA A | ||||
| CTA TCT GAT TGT TGA AGA AGG ATT | ||||
| GTT TAC TCT TGG TTT AGG ATG AAA | ||||
| CTT GTT GAT CAC GAT AAT TTC C | ||||
| ATC TTT TAG CAA ACC CGT ATT C | ||||
| Penicillin | ACT TCA ACA CCT GCT GCT TTC | |||
| TGA CCA CTT TTA TCA GCA ACC | ||||
| Gentamicin, amikacin | TAA TCC AAG AGC AAT AAG GGC | |||
| GCC ACA CTA TCA TAA CCA CTA | ||||
| Vancomycin | GCT GTG AGG TCG GTT GTG | [ | ||
| GCT CGA CTT CCT GAT GAA TAC G | ||||
|
| Linezolid, chloramphenicol | AGG TGG TCA GCG AAC TAA | [ | |
| ATC AAC TGT TCC CAT TCA | ||||
| Linezolid | GTA ACG ATC ATC ATT TGG G | This study | ||
| CTT TAT TAG AGC TCA ATG GGC | ||||
|
| Oxazolidinones | TGA AGT ATA AAG CAG GTT GGG AGT CA | [ | |
| ACC ATA TAA TTG ACC ACA AGC AGC |
Presence of antibiotic resistance genes in coagulase-negative Staphylococcus spp. and phenotypic linezolid resistance.
| Isolate 17CS | Age (d) | Governorate | Species | Resistance-Associated Genes | Linezolid Resistance (mg/L) |
|---|---|---|---|---|---|
| 0271-1 | 365 | Dakahlia |
| 8 | |
| 0275-1 | 365 |
| 8 | ||
| 0275-2 | 365 |
| 1 | ||
| 0281-1 | 365 |
| 1 | ||
| 0283-1 | 365 |
| 8 | ||
| 0286-2 | 365 |
| 8 | ||
| 0288-2 | 365 |
| 2 | ||
| 0294 | 6 |
| 8 | ||
| 0298 | 6 |
| 8 | ||
| 0300 | 6 |
| 8 | ||
| 0303 | 6 |
| 8 | ||
| 0306 | 240 | Damietta |
| 8 | |
| 0307-2 | 240 |
| 8 | ||
| 0310-2 | 240 |
| 8 | ||
| 0311 | 240 |
| 8 | ||
| 0312-1 | 240 |
| 8 | ||
| 0314 | 240 |
| 8 | ||
| 0314-1 | 240 |
| 8 | ||
| 0316 | 240 |
| 8 | ||
| 0317 | 240 |
| 8 | ||
| 0318-1 | 240 |
| 8 | ||
| 0321-1 | 240 |
| 8 | ||
| 0322-2 | 240 |
| 8 | ||
| 0323-2 | 240 |
| 2 | ||
| 0327 | 240 |
| 8 | ||
| 0330-1 | 240 |
| - | 1 | |
| 0336 | 10 |
| 8 | ||
| 0338 | 10 |
| 1 | ||
| 0339-2 | 10 |
| 8 | ||
| 0340 | 21 | Sharkiya |
| 8 | |
| 0346 | 21 |
| 8 | ||
| 0347-2 | 21 |
| 1 | ||
| 0349 | 21 |
| 8 | ||
| 0353-1 | 75 |
| 2 | ||
| 0358 | 75 |
| 8 | ||
| 0366 | 75 |
| 8 | ||
| 0368 | 60 | Kafr El-Sheikh |
| 8 | |
| 0370 | 60 |
| 8 | ||
| 0397 | 123 | Gharbia |
| 8 |